Jiangzhong Pharmaceutical (600750.SH) plans to invest 40 million yuan in the second phase of the China Resources Pharmaceutical Industry Investment Fund.

Zhtng Cijng APP news, Jiang Zhong Pharmaceutical (600750.SH) announced that the company plans to jointly establish the CR Pharma (Chengdu) Innovation Investment Fund Limited Partnership (tentative name) with 10 limited partners including China Resources Pharm Holdings Co., Ltd., CR Pharmaceutical Investment Co., Ltd., CR BoYa Bio-Pharmaceutical Group Co., Ltd., Dong-E-E-Jiao Co., Ltd., CR Double-Crane Pharmaceutical Co., Ltd., and Chengdu Run Pharmaceutical Industry Investment Limited Partnership (tentative name). The fund has a size of 1 billion RMB, and CR Capital Equity Investment Co., Ltd. in Shenzhen will be the fund manager. The company, as a limited partner, will contribute a total of 40 million RMB with its own funds and hold a 4% ownership stake in the fund.